To access this element change to forms mode OFF
Grant Award View - GA218189-V1
Targeting fatty acid oxidation, a novel approach for prostate cancer...
GA ID:
GA218189-V1
Agency:
Cancer Australia
Approval Date:
16-Feb-2022
Variation Publish Date:
30-Mar-2022
Variation Date:
30-Jun-2022
Category:
Cancer
Grant Term:
30-Jun-2022 to 29-Jun-2024
Value (AUD):
$36,600.00
(GST inclusive where applicable)
Varies:
GA218189
- Targeting fatty acid oxidation, a novel approach for prostate cancer treatment
One-off/Ad hoc:
No
Aggregate Grant Award:
No
PBS Program Name:
CA 21/22 Improved cancer control
Grant Program:
2021 Priority-driven Collaborative Cancer Research Scheme
Grant Activity:
Targeting fatty acid oxidation, a novel approach for prostate cancer treatment
Purpose:
Cancer cells are characterised by uncontrolled cell proliferation, the ability to migrate and invade into other tissue, and resistance to treatment. These cellular capabilities require the production of additional energy by the cell. Prostate cancer cells rely mainly on lipids as fuel to supply the increasing demands on energy. Targeting the machineries (enzymes) that the cells use to break down lipids into energy may be a new way to slow tumour growth and metastasis.
GO ID:
GO Title:
2021 Priority-driven Collaborative Cancer Research Scheme for funding commencing in 2022
Internal Reference ID:
2011672_Nassar
Selection Process:
Targeted or Restricted Competitive
Confidentiality - Contract:
No
Confidentiality - Outputs:
No
Grant Recipient Details
Recipient Name:
The University of Adelaide
Recipient ABN:
61 249 878 937
Grant Recipient Location
Suburb:
The University of Adelaide
Town/City:
Adelaide
Postcode:
5005
State/Territory:
SA
Country:
AUSTRALIA
Grant Delivery Location
State/Territory:
SA
Postcode:
5005
Country:
AUSTRALIA